Product
Chloroprocaine
8 clinical trials
12 indications
Indication
CataractIndication
HerniaIndication
InguinalIndication
Flat FootIndication
Unplanned Cesarean SectionIndication
AntisepticIndication
AnesthesiaIndication
LocalIndication
spinalIndication
c-sectionIndication
Local AnaestheticIndication
Obstetric LaborClinical trial
Randomized, Multi-center, Double-blind, Two-armed, Parallel Active Groups, Prospective Trial, to Evaluate, in Pediatric Population, the Efficacy and Safety of Chloroprocaine 1% and 2% for Peripheral Nerve Block.Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
A Prospective, Observer-masked, Randomized Clinical Trial to Investigate and Compare the Clinical Efficacy of Chloroprocaine 3% Gel and Tetracaine 0.5% Eye Drop as Topical Anestheticsin Phacoemulsification.Status: Completed, Estimated PCD: 2021-03-01
Clinical trial
Comparison of Epidural Chloroprocaine 3% and Ropivacaine 0.75% for Unplanned Caesarean Section in Labouring Women Who Have an Epidural Catheter in SituStatus: Terminated, Estimated PCD: 2021-06-01
Clinical trial
The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-Iodine: A Comparison vs Tetracaine 0.5% Solution.Status: Recruiting, Estimated PCD: 2024-01-15
Clinical trial
The Maternal CLIMB Trial: Chloroprocaine to Reduce the Impact of Motor Block on Patient Recovery After Short Obstetric SurgeryStatus: , Estimated PCD: 2024-06-04
Clinical trial
Intrathecal Use of Chloroprocaine 1% and Ropivacaine 0,75% During Elective Cesarean Section. A Comparative StudyStatus: Recruiting, Estimated PCD: 2026-01-10
Clinical trial
A Prospective, Observer-blind, Randomized Clinical Trial to Investigate and Compare the Clinical Efficacy of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia for Clinical Practice in Pediatric PopulationStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Efficacy and Safety of Chloroprocaine Versus Ropivacaine for Epidural Labor Analgesia Study: a Randomized, Double-blind, Controlled, Multicenter, Noninferiority Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2025-06-16